Description
The “2ml” designation refers to the volume of the vaccine. Each dose of Rotateq is typically administered orally and consists of 2 milliliters (ml) of liquid.
Rotateq is a live, oral vaccine that contains five reassortant strains of the rotavirus. These strains have been weakened so that they can stimulate the immune system to produce antibodies against rotavirus without causing illness. By triggering an immune response, Rotateq helps the body recognize and fight off rotavirus infection if the child is exposed to the virus in the future.
Rotateq is usually given to infants in a series of doses starting at around 6 weeks of age, with subsequent doses given at intervals determined by the healthcare provider. The specific dosing schedule may vary depending on the age of the infant at the time of vaccination and other factors.
As with any vaccine, Rotateq can cause side effects, though they are generally mild and uncommon. Common side effects may include irritability, mild diarrhea, vomiting, or mild fever. Serious side effects are rare but possible.
It’s important for parents and caregivers to discuss the Rotateq vaccine with a healthcare provider to understand the recommended schedule and potential risks and benefits. Rotateq is recommended by health authorities as part of routine childhood immunization schedules to help protect infants against rotavirus infection.
